510(k) K252102
K252102 is an FDA 510(k) premarket notification submitted by Abbott Molecular, Inc. for the device "Alinity m HCV". The FDA issued a decision of Substantially Equivalent on Sep 25, 2025. The device falls under product code MZP (Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus), a Class II device regulated under 21 CFR 866.3170. Abbott Molecular, Inc. has 18 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 25, 2025
- Date Received
- Jul 3, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
- Device Class
- Class II
- Regulation Number
- 866.3170
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Abbott Molecular, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.